Guillon C - Search Results

1

Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction.

Guillon C, Schutten M, Boers PH, Gruters RA, Osterhaus AD. Guillon C, et al. J Virol. 2002 Mar;76(6):2827-34. doi: 10.1128/jvi.76.6.2827-2834.2002. J Virol. 2002. PMID: 11861850 Free PMC article.

2

Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities.

Guillon C, van der Ende ME, Boers PH, Gruters RA, Schutten M, Osterhaus AD. Guillon C, et al. J Virol. 1998 Jul;72(7):6260-3. doi: 10.1128/JVI.72.7.6260-6263.1998. J Virol. 1998. PMID: 9621102 Free PMC article.

3

Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model.

van Der Ende ME, Guillon C, Boers PH, Gruters RA, Racz P, Tenner-Racz K, Osterhaus AD, Schutten M. van Der Ende ME, et al. Among authors: guillon c. J Gen Virol. 2000 Feb;81(Pt 2):507-13. doi: 10.1099/0022-1317-81-2-507. J Gen Virol. 2000. PMID: 10644850 Free article.

4

Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure.

Schutten M, van Baalen CA, Guillon C, Huisman RC, Boers PH, Sintnicolaas K, Gruters RA, Osterhaus AD. Schutten M, et al. Among authors: guillon c. J Virol. 2001 Mar;75(6):2706-9. doi: 10.1128/JVI.75.6.2706-2709.2001. J Virol. 2001. PMID: 11222694 Free PMC article.

5

Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in Nef.

Guillon C, van Baalen CA, Boers PH, Verschuren EJ, Gruters RA, Osterhaus AD. Guillon C, et al. J Virol Methods. 2002 Jan;99(1-2):115-21. doi: 10.1016/s0166-0934(01)00389-5. J Virol Methods. 2002. PMID: 11684309 Free article.

6

Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.

van Baalen CA, Guillon C, van Baalen M, Verschuren EJ, Boers PH, Osterhaus AD, Gruters RA. van Baalen CA, et al. Among authors: guillon c. Eur J Immunol. 2002 Sep;32(9):2644-52. doi: 10.1002/1521-4141(200209)32:9<2644::AID-IMMU2644>3.0.CO;2-R. Eur J Immunol. 2002. PMID: 12207349 Free article.

7

Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy.

van der Ende ME, Guillon C, Boers PH, Ly TD, Gruters RA, Osterhaus AD, Schutten M. van der Ende ME, et al. Among authors: guillon c. J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):11-8. doi: 10.1097/00042560-200009010-00002. J Acquir Immune Defic Syndr. 2000. PMID: 11064499

8

Blood monocytes infected in vivo by HIV-1 variants with a syncytium-inducing phenotype.

Innocenti-Francillard P, Brengel K, Guillon C, Mallet F, Morand P, Gruters R, Seigneurin JM. Innocenti-Francillard P, et al. Among authors: guillon c. AIDS Res Hum Retroviruses. 1994 Jun;10(6):683-90. doi: 10.1089/aid.1994.10.683. AIDS Res Hum Retroviruses. 1994. PMID: 8074932

9

The choice of antigen for therapeutic immunization against AIDS.

van Baalen CA, Stittelaar KJ, Osterhaus AD, Guillon C, Gruters RA. van Baalen CA, et al. Among authors: guillon c. Trends Immunol. 2002 Oct;23(10):478-9. doi: 10.1016/s1471-4906(02)02304-9. Trends Immunol. 2002. PMID: 12297418

10

Molecular characterization of HIV viruses generated after in vivo ligation.

Guillon C, Oriol G, Gruters RA. Guillon C, et al. J Virol Methods. 1997 Jul;66(2):237-46. doi: 10.1016/s0166-0934(97)00061-x. J Virol Methods. 1997. PMID: 9255735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters